About this trial
This study is a randomized controlled trial that will evaluate the effect of non-invasive auricular vagal nerve stimulation on inflammatory markers, glycemic control, postoperative pain, and inflammation-related clinical outcomes after long-segment spinal fusion surgeries when compared to current accepted management.
Eligibility criteria
Qualifiers
Long-segment spinal fusions (defined as constructs spanning at least L2-pelvis for thoracolumbar fusions or C2-T2 for cervical fusions)
Ability to undergo a reliable neurologic examination and pain assessments
Disqualifiers
Patients <18 years of age
Shorter-segment spinal fusions than those described above
Undergoing current active cancer therapy
Undergoing treatment with immunosuppressive drugs
Trial design
Treatments tested in this trial
- Auricular vagus nerve stimulation
- Sham Auricular Vagus nerve Stimulation
Treatment groups
Sponsors and collaborators
Alexander T. Yahanda
Lead sponsor
Washington University School of Medicine
Sponsor institution